Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Semaglutide and Tirzepatide in Patients with Heart Failure with Preserved Ejection Fraction

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Late-Breaking Clinical Science: cardiometabolic medicine

Access
Like
Thumbnail

Predicting individualized treatment effects of prasugrel vs ticagrelor for acute coronary syndrome: a post hoc analysis of a randomized clinical trial

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Pharmacotherapy to improve outcomes in coronary disease

Access
Like
Thumbnail

Real-world evidence supports superior efficacy of prasugrel over ticagrelor in individuals with acute coronary syndrome

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Tailored approaches to cardiovascular therapy in acute coronary syndromes

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources